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Abstract
Background: Muscarinic receptors (mAChRs) of the preoptic and anterior hypothalamus areas (POA-AHA) regulate
ovulation in an asymmetric manner during the estrous cycle. The aims of the present study were to analyze the
effects of a temporal blockade of mAChRs on either side of the POA-AHA performed in diestrus-2 rats on ovulation,
the levels of estradiol, follicle stimulating hormone (FSH) and luteinizing hormone (LH) and the mechanisms
involved in changes in ovulation.
Methods: Cyclic rats on diestrus-2 day were anesthetized and randomly assigned to the following groups: 1)
microinjection of 1 μl of saline or atropine solution (62.5 ng) in the left or right POA-AHA; 2) removal (unilateral
ovariectomty, ULO) of the left (L-ULO) or right (R-ULO) ovary, and 3) rats microinjected with atropine into the left or
right POA-AHA plus L-ULO or R-ULO. The ovulation rate and the number of ova shed were measured during the
predicted estrus, as well as the levels of estradiol, FSH and LH during the predicted proestrus and the effects of
injecting synthetic LH-releasing hormone (LHRH) or estradiol benzoate (EB).
Results: Atropine in the left POA-AHA decreased both the ovulation rate and estradiol and LH levels on the
afternoon of proestrus, also LHRH or EB injection restored ovulation. L- or R-ULO resulted in a lower ovulation rate
and smaller number of ova shed, and only injection of LHRH restored ovulation. EB injection at diestrus-2 restored
ovulation in animals with L-ULO only. The levels of estradiol, FSH and LH in rats with L-ULO were higher than in
animals with unilateral laparotomy. In the group microinjected with atropine in the left POA-AHA, ovulation was
similar to that in ULO rats. In contrast, atropine in the right POA-AHA of ULO rats blocked ovulation, an action that
was restored by either LHRH or EB injection.
Conclusions: These results indicated that the removal of a single ovary at noon on diestrus-2 day perturbed the
neuronal pathways regulating LH secretion, which was mediated by the muscarinic system connecting the right
POA-AHA and the ovaries.
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Background
The preovulatory period of the estrous cycle is character-
ized by the rapid growth of ovarian follicles and the in-
creased secretion of estradiol (E2). Plasma levels of E2 are
low on estrus day, increasing its levels from the afternoon
of diestrus-1 day until the morning of diestrus-2 day, reach-
ing the highest levels between morning and noon on the
proestrus day [1]. Ovarian E2 secreted on diestrus-2 day is
required to activate the LH surge on proestrus day, since
the injection of estrogen antagonists [2] or estradiol anti-
serum [3] or ovariectomy [4] during diestrus-2 day block
the preovulatory LH surge.
The LH surge is the result of an increase in the fre-
quency and amplitude of pulses of secretion of
gonadotropin-releasing hormone (GnRH) in the POA-
AHA, in response to activation of several molecules
present in the neural network GnRH [5], such as neu-
rons that synthesize acetylcholine (ACh). Importantly,
ACh regulates the secretion of GnRH, LH, and FSH as
well as stimulates the weight of ovaries, the ovarian
compensatory hypertrophy in ULO of the rats [6–9].
Interestingly, the participation of the muscarinic cholin-
ergic system is relevant to the regulation of ovulation
which varies throughout the estrous cycle and has a
circadian rhythm [10].
The continuous blockade of mAChRs by implants of
atropine crystals on either side of the POA-AHA
blocked ovulation depending on the day of the estrous
cycle [6]. Similar effects were observed when pilocar-
pine, a specific agonist of mAChRs, was administered in
the POA-AHA [11]. Previous studies performed by our
group showed that ULO rats with implants of atropine
in the left POA-AHA during the estrus day did not ovu-
late, while the majority of rats with implants in the right
POA-AHA did. Furthermore, the injection of EB re-
stored ovulation in animals with atropine implants in
the left POA-AHA [12]. These observations suggested
that the cholinergic muscarinic system in the POA-AHA
exerted an asymmetric regulating action on spontaneous
ovulation through the modutation of GnRH secretion.
The aim of the present study was to examine whether
or not the muscarinic system in the POA-AHA partici-
pates in regulating ovulation on a permanent or tempor-
ary manner. To answer this, we analyzed the effects of
ULO on spontaneous ovulation in rats microinjected
with atropine into the POA-AHA.
Methods
Animals
The study was carried out in 3–4 month old female
virgin rats (195–225 g), of the CIIZ-V strain, from our
own production stock. The animals were kept under con-
trolled light (05:00–19:00 h) and temperature (22 ± 2 °C)
conditions, with free access to tap water and a standard
rodent diet (Harlan, SA, Mexico City, Mexico). Estrous cy-
cles were monitored by examining daily vaginal smears,
and only animals with at least two consecutive estrous
cycles of 4 days each were used in the experiments. All
treatments were performed from 12:30 to 13:30 h on
diestrus-2 day. After surgery (described below), each ani-
mal was placed in a cage with sawdust, warmed with an
incandescent lamp until they awoke. After the treatments,
vaginal smears were obtained again at 24 h after abdom-
inal or brain surgery. Lastly, the animals were sacrificed at
10:00 h on the predicted estrus.
To investigate if the muscarinic system of the POA-
AHA is involved in regulating ovulation on a transient
or more long-term manner, we designed three different
sets of experiments as follows: 1) microinjection of atro-
pine into the left or right POA-AHA; 2) left or right
ULO; and 3) left or right ULO, followed of blockade of
the mAChRs in the left or right POA-AHA (Fig. 1).
Additionally, to investigate the mechanisms affected by
blocking mAChRs at 14.00 h of the predicted proestrus
day, groups of animals microinjected with atropine in
left POA-AHA, left or right ULO or left or right ULO
followed by blockade of the mAChRs in the left or right
POA-AHA were injected with synthetic LH-releasing
hormone (LHRH)-Gly-OH or with estradiol benzoate
(EB). Finally, the levels of estradiol, FSH and LH were
measured in the morning and afternoon of expected
proestrus of animals microinjected with atropine in the
left or right POA-AHA or with left or right ULO.
Experiment 1. Effects of the transient blockade of mAChRs
in the left or right POA-AHA on spontaneous ovulation
(Fig. 1A)
To investigate the effects of unilateral transient blockade
of mAChRs in the POA-AHA on ovulation, microinjec-
tions of atropine (a competitive and reversible antagonist
of five mAChRs (m1-m5) [7, 13] were performed in the
left or right POA-AHA of rats. The animals were anes-
thetized with an intraperitoneal injection of sodium
pentobarbital (30 mg/kg; Anestesal, Smith-Kline Norden
of México City, Mexico) and placed in a stereotaxic ap-
paratus (David Kopff Instruments, Tujunga, CA, USA).
An incision in the skin of the dorsal region of the head
was made subsequently the left or right side of the skull
was exposed and drilled with a stainless steel 1 mm
diameter drill. Next, a 29-gauge stainless steel needle
was inserted into the left or right POA-AHA. The
location of the POA-AHA was determined according to
the coordinates (AP 0.650 mm± 0.06 mm lateral, vertical
0.86 mm) from the König and Klippel Atlas [14]. The
microinjection needle was connected through a piece of
Teflon tubing (OD 0.65 mm 0.12 mm OI 9; Bioanalytical
Systems, Inc., West Lafayette, IN, USA) to a 20-μl
Hamilton syringe mounted on a pump microinjector
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(CMA/100, BAS, Stockholm, Sweden). Rats were ran-
domly assigned to different groups (n = 8–10 animals
per group) and microinjected as follows: 1) vehicle: sa-
line solution 1 μl; 2) atropine, 62.5 ng/μl (Sigma-Aldrich,
Mexico); and 3) intact: cyclically untreated rats. The
dose of atropine was selected based on previous studies
in our laboratory [6, 12]. All test solutions were injected
at a rate of 1 μl/min.
Experiment 2. Effects of left or right ULO on spontaneous
ovulation (Fig. 1b)
To evaluate the role of each ovary in the physiological
mechanisms regulating spontaneous ovulation at 13:00 h
of diestrus-2 day, the rats were anesthetized and were
randomly assigned to one of the experimental groups
described below.
Intact Group: Cyclical rats without treatment, sacrificed
at 10:00 h of estrus day.
Unilateral Laparotomy: A unilateral incision was made
1 cm below the last rib, throughout the skin, muscle
and peritoneum. The ovaries were left untouched. At
the end of the surgical procedure, the wound was
sealed.
Unilateral Ovariectomy (ULO): A unilateral incision was
made below the last rib, throughout the skin, muscle and
peritoneum, and the left or right ovary was carefully
removed. The wound was subsequently sealed.
Experiment 3. Effects of the transient unilateral blockade of
the mAChRs in the POA-AHA region in ULO rats on
spontaneous ovulation (Fig. 1c)
To test our hypothesis that the ovary is critical in
controlling spontaneous ovulation mediated by the
muscarinic system in the hypothalamus, we combined
L- or R-ULO with microinjections of atropine in the left
or right POA-AHA. The rats were treated as described
in experiments 1 and 2. The abdominal and brain sur-
geries were performed back to back on the same day.
Postmortem procedures
On the day of expected estrus (46 h after ULO), the rats
were sacrificed by decapitation [15], the oviducts were
dissected and the number of ova shed was counted using
a dissecting microscope (Olympus SZ51-LGB, Tokyo,
Japan). Next, the ovaries were removed, dissected and
weighed on a precision balance (Mettler, AT-261,
Switzerland). The brain was also rapidly dissected and
fixed in paraformaldehyde solution (4 % v/v). The ovula-
tion rate (number of animals that ovulated/total number
of treated rats) was expressed as the percentage of rats
that ovulated.
Hormonal replacement with LHRH or EB in non-ovulating rats
A separate group of animals that received micro-
injections of atropine in the left POA-AHA were also
injected subcutaneously (sc) with 3.7 μg/kg of LHRH
(Sigma Chemical Co. St. Louis, MO, USA) at 14:00 h of
predicted proestrus day as described [16], or with 10 μg
of EB (Sigma Chemical Co.) at 14:00 h on diestrus-2 day
as described [17]. All animals were sacrificed on the
morning of predicted estrus.
Measurement of serum hormone levels
A different group animals treated as described above
(experiment 1 or 2) was sacrificed at 11:00 or 17:00 h of
the expected proestrus day to measure the levels of E2,
FSH and LH. E2 was measured using enzyme-linked
a) b) c)
Fig. 1 Schematic representation of the experimental design: a Experiment 1: Groups of rat’s microinjected with vehicle or atropine in the left or
right side of POA-AHA at 13:00 h during diestrus-2. b Experiment 2: Rats subjected to removal of the left (left-ULO) or right ovary (right-ULO) at
13:00 h during diestrus-2. c Experiment 3: Group of left-ULO or right-ULO rats microinjected with atropine in the left or right POA-AHA at 13:00 h
during diestrus-2. All animals were sacrificed on the predicted estrus day
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immunoassay (ELISA) kits (AccuBind, Monobind Inc.,
Lake To-est, CA, USA), the assay sensitivity was 6.5 pg/ml.
The levels of FSH and LH were measured by radioimmuno-
assay (RIA) methods with specific reagents and protocols
from the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK), distributed by Dr. A. F. Parlow:
LH (NIDDK-HLR-I 125-S-11) and FSH (NIDDK-recombin-
ant FSH-I125-I-9). The intra-assay and inter-assay
coefficients of variation for LH and FSH were 12.1 and
14.6 %, respectively, and the sensitivity of the assays for both
hormones was 0.1 ng/ml.
Brain histological procedures
To verify the accuracy of the microinjection site, 100-μm
sections of the POA-AHA region were obtained with a
vibratome (Technical Products International Inc, St.
Louis, MO, USA). The sections were mounted on slides
and immediately examined under a stereoscopic micro-
scope. Only results from rats with verified microinjection
into the POA-AHA [18].
Statistical analyses
All statistical analyses were performed with GraphPad
InStat3 Software, Inc. (San Diego, CA, USA). Ovulation
rate results were analyzed using Fisher’s exact probability
test or the Chi-square test. Data on the number of ova
shed were analyzed using the Kruskal-Wallis test followed
by Dunn’s test. Data on ovarian weight and estradiol, FSH
and LH levels were subjected to multivariate analysis of
variance (MANOVA) followed by Turkey’s test. All values
were expressed as the mean ± S.E.M. A probability value
(p) ≤ 0.05 % was considered statistically significant.
Results
Effects of transient blockade of mAChR in the left or right
POA-AHA on spontaneous ovulation
The ovulation rate, number of ova shed and ovarian
weight were similar in the vehicle and the intact group.
The ovulation rate was lower in animals with atropine
injected in the left POA-AHA than in the vehicle group,
and it did not change when atropine was injected in the
right side. The number of ova shed by animals with atro-
pine injected into the right POA-AHA was lower than
in the vehicle group (Table 1). No differences in ovarian
weight between groups were observed. Rats with
atropine in the left POA-AHA ovulated 48 h after the
predicted estrus day (8/8 vs. 2/10, p < 0.001).
Ovulation was induced in 100 % of animals microin-
jected with atropine in the left POA-AHA that later re-
ceived injections of synthetic LHRH (atropine + LHRH
5/5 vs. atropine 2/8, p < 0.0210, Fisher’s exact test). A
similar result was obtained when EB was injected (atro-
pine + EB 5/5 vs. atropine 2/8, p ≤ 0.0216).
Effects of left or right ULO on spontaneous ovulation
On the predicted estrus day, the ovulation rate of the left
or right laparotomized groups was similar to that in the
intact group. However, the ovulation rate was lower in
animals with ULO, compared to the respective laparoto-
mized only groups. The number of ova shed by the
remaining ovary (left ovary) in the right ULO group was
lower than in the right laparotomized groups. In con-
trast, no changes were observed between left ULO and
left laparotomized rats except for one single rat ovulat-
ing in the left ULO group (Table 2). The weight of the
ovaries in the right laparotomized animals was higher
than those in the intact group. However, the weight of
the in situ ovaries in the left and right ULO groups were
even higher than in the respective laparotomized groups
(Table 2). In animals with ULO, vaginal estrus occurred
24 h after ULO. On this day, the animals with left ULO
did not ovulate but right ULO rats did.
Injection with LHRH re-established ovulation in all
rats with ULO (left ULO + LHRH 5/5 vs. left ULO: 1/10;
right ULO + LHRH 5/5 vs. right ULO: 3/9, p < 0.01 Fish-
er’s exact probability test). In animals with right ULO
(left ovary in situ), replacement with EB induced ovula-
tion in all treated animals, while in animals with left
ULO (right ovary in situ), EB treatment induced ovula-
tion only in 33 % of the treated animals (Fig. 2).
The number of ova shed by animals with right ULO
injected with LHRH was higher than in animals with
right ULO and no hormone injection (8.8 ± 0.9 vs. 2.0 ±
0.6, p < 0.01). LHRH injection in animals with left ULO
resulted in higher number of ova shed (7.2 ± 0.4), com-
pared to the single animal with left ULO not treated
with LHRH that ovulated (4 ova shed). The number of
ova shed by animals with right ULO injected with EB
was higher than that of rats with ULO (7.0 ± 0.7 vs. 2.0
± 0.6, p < 0.01). Rats with left ULO and EB injection re-
leased a similar number of ova as the group that did not
Table 1 Ovulation in rats with unilateral atropine microinjection






Left ovary Right ovary
Intact – 10 10/10 7.1 ± 0.5 5.4 ± 0.3
Vehicle Left 9 9/9 6.1 ± 0.9 4.2 ± 1.0
Right 9 9/9 6.5 ± 0.2 4.8 ± 0.3
Atropine Left 10 2/10a 4, 0** 3, 3**
Right 10 10/10 3.1 ± 0.3b 1.7 ± 0.2b
The ovulation rate and the number of ova shed (mean ± SEMs) by rats
subjected to microinjection of the vehicle or atropine into the left or right side
of the POA-AHA region were measured at the predicted estrus day
ap < 0.0007 vs. left vehicle (Fisher’s exact probability test)
bp < 0.001 vs. right vehicle (Kruskall Wallis test, followed Dunn test)
**represents the number of ova shed by the two ovulating rats
*Number of ovulating animals/number of treated animals
Espinosa-Valdez et al. Reproductive Biology and Endocrinology  (2016) 14:75 Page 4 of 9
receive hormone treatment (2.3 ± 0.9). The weight of the
in situ ovaries in animals with left or right ULO and
LHRH or EB was lower than in ULO animals without
hormonal replacement (Table 3).
Effects of transitory mAChR blockade in the POA-AHA of
ULO rats on spontaneous ovulation
The ovulation rate was not modified in ULO rat micro-
injected with atropine in the left side of the POA-AHA,
while ovulation was blocked by atropine was in the right
POA-AHA (Fig. 3). The number of ova shed (data not
shown) in ULO rats injected with atropine in either side
of the POA-AHA was as low as that in ULO only rats
(data not shown).
The weight of the in situ ovaries in ULO rats plus at-
ropine injected in either side of the POA-AHA was
lower than that in ULO only rats (left ULO + left POA-
AHA: 15.0 ± 0.8, left ULO + right POA-AHA: 17.6 ± 0.9
vs. left ULO: 32.7 ± 3.3, p < 0.01; right ULO + left POA-
AHA: 15.1 ± 0.7, right ULO + right POA-AHA: 17.9 ±
0.4 vs. right ULO: 33.4 ± 3.6, p < 0.001).
In ULO animals’ microinjected with atropine in either
side of the POA-AHA, the number of ova shed induced
upon replacement of LHRH or EB, depended on what
ovary was remained in situ. For example, the injection of
LHRH in animals retaining the right ovary in situ and
microinjected with atropine in the right POA-AHA,
shed a higher number of ova than the ULO alone group.
By contrast, rats with the left ovary in situ microinjected
with atropine in either POA-AHA released a smaller
number of ova after LHRH injection (Fig. 4).
In ULO animals with the right ovary in situ, microinjec-
tion with atropine in the right or left POA-AHA and EB
replacement resulted in a higher number of ova shed than
in the ULO alone group. The injection of EB in rats with
the left ovary in situ and atropine microinjection in either
side of the POA-AHA did not modify the number of ova
compared to ULO rats (Fig. 4).
Table 2 Ovulation in rats with unilateral ovariectomy (ULO) performed at 13:00 h of diestrus-2 day
Group Ovulation rate* Number of ova shed by the in situ ovary Weight of the in situ ovary (mg/100 g bw)***
Left ovary Right ovary Left ovary Right ovary
Intact 10/10 7.1 ± 0.5 5.4 ± 0.3 16.5 ± 1.2 15.6 ± 1.2
L-laparotomy 9/10 3.2 ± 1.3b 4.8 ± 2.6 14.9 ± 1.3 15.6 ± 1.4
L-ULO 1/10a – 4** – 32.7 ± 3.3a
R-laparotomy 10/10 6.2 ± 1.4 6.0 ± 1.1 24.9 ± 4.0b 21.7 ± 2.2b
R-ULO 3/9a 2.0 ± 0.6c – 33.4 ± 3.6a –
The ovulation rate and the number of ova shed (mean ± SEMs) and weight of the left or right ovary of intact rats, or rats subject to left (L-laparatomy) or right
(R-laparotomy) laparotomy, and those subject to left (L-ULO) or right (R-ULO) ULO were measured at the predicted estrus day
ap < 0.01 vs. respective laparotomy group (Fisher’s exact probability test)
bp < 0.01 vs. respective intact group (Kruskall Wallis test, followed Dunn test)
cp < 0.01 vs. respective laparotomy group (Kruskall Wallis test, followed Dunn test)
***data statistically analyzed by ANOVA followed by Tukey test
**represents the number of ova shed by the ovulating rat
*Number of ovulating animals/number of treated animals
Fig. 2 Effects of EB on ovulation in ULO rats. Ovulation rate of the
left or right in situ ovary of rats subject to left ULO (L-ULO) or right
ULO (R-ULO), and ULO rats subsequently injected with 10 μg of EB
at 14:00 h on the same day of ULO. The animals were sacrificed at
the predicted estrus day. a p < 0.01 vs. the respective ULO only
group (Fisher’s Exact Probability test)
Table 3 Effects of LHRH or EB on the weight of the in situ ovary
in rats with unilateral ovariectomy (ULO) performed at 13:00 h
of diestrus-2 day
Group Weight of the in situ ovary (mg/100 g bw)
Left Right
L-ULO – 32.7 ± 3.3
L-ULO + LHRH – 17.4 ± 1.1a
L-ULO + EB – 19.6 ± 1.2a
R-ULO 33.4 ± 3.6 –
R-ULO + LHRH 19.7 ± 1.5a –
R-ULO + EB 18.0 ± 1.3a –
The mean ± SEMs of the weight of the left or right ovary of intact rats, or rats
subject to left ULO (L-ULO) or right ULO (R-ULO), and ULO rats injected with
3.7 μg/Kg body weight of synthetic LHRH at 14:00 h of the predicted proestrus
day, or injected with 10 μg of EB at 14:00 h of the same day of the ULO. The
animals were sacrificed at the predicted estrous day
ap < 0.01 vs. the respective ULO group (MANOVA, followed Tukey test)
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Fig. 3 Effects of atropine microinjection into the left (L-atropine) or right (R-atropine) POA-AHA on ovulation in left-ULO (L-ULO) or right-ULO (R-ULO)
rats. The animals were sacrificed at the predicted estrus day. a p < 0.01 vs. R-atropine group (Fisher’s Exact Probability test)
Number of ova shed by ULO rats with unilateral atropine 
microinjection injected with LHRH or EB
Fig. 4 Mean ± SEM of the number of ova shed by ULO rats with unilateral atropine microinjection in the POA-AHA, treated with LHRH or EB. The
number of ova shed from the left or right in situ ovary of rats subjected to left or right ULO plus atropine microinjection into the left (L-atropine)
or right (R-atropine) POA-AHA, performed at 13:00 h of diestrus-2 and sacrificed at predicted estrus day. a p < 0.01 vs. the respective ULO only
group (ANOVA followed Tukey test)
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Effects of transitory mAChR blockade in the left or right
POA-AHA on serum hormone levels
At 11:00 h of the predicted proestrus day, the serum
levels of E2, LH and FSH were similar in all of the ex-
perimental groups. However, at 17:00 h animals microin-
jected with atropine in the left POA-AHA had lower E2
and LH serum levels than the vehicle group, while rats
treated in the right POA-AHA had levels similar to the
vehicle group. FSH levels were higher in animals treated
with atropine on the left or right side of the POA-AHA
than in vehicle-treated rats (Table 4).
Effects of left or right ULO on hormone serum level
measurements
At 11:00 h of the predicted proestrus day, E2, LH and
FSH serum levels in left ULO rats were higher than
those in the left sham group while right ULO did not
modify E2 levels, but increased LH and FSH levels com-
pared to sham operated rats. At 17:00 h on the predicted
proestrus day, LH serum levels in the sham rats were
lower than in the intact group. LH and FSH levels in
ULO rats were lower than in the sham group (Table 5).
Discussion
In the present study, transient blockade of the mAChRs
in the POA-AHA with atropine modified the ovulation
process: it inhibited the ovulation rate when the block-
ade is the left POA-AHA or reduced the number of ova
shed when the right POA-AHA was treated with
atropine.
We think that the effect of the atropine on right POA-
AHA on the number of ova shed but not on ovulation
rate may be explained for the lack of muscarinic signals
in the POA-AHA to the ovary for the growth and differ-
entiation of follicles. Previously, our group showed that
the ovaries of rats with implants of atropine in the POA-
AHA had fewer small follicles in the left ovary compared
to control group [19].
Regarding the decrease in the levels of the E2 and LH
on the afternoon of proestrus day after temporary block-
ade of the muscarinic system of the left POA-AHA, and
considering that injection of EB restored ovulation, we
believe that these low levels of E2 are the cause of the
observed blockade of ovulation. These results support
the idea that neural signals arising from the left side of
the POA-AHA modulate the sensitivity of the ovaries to
FSH and LH [19] and by the muscarinc system. In fact,
studies performed with subcutaneous injection of
atropine on the diestrus-1 day causes a 24-h delay on
preovulatory LH and E2 levels, and ovulation [20]. Fur-
thermore, the neural information coming from each side
of the hypothalamus differentially regulates ovulation in
the right and left ovary [19, 21]. Thus, the present study
suggests that approximately at noon on diestrus-2 day,
the muscarinic system innervating the left POA-AHA
regulates in a stimulatory manner the preovulatory se-
cretion of LH, indicating that activation of mAChRs is a
key component in stimulating feedback of estrogens and
in the pre-ovulatory surge of GnRH.
Table 4 Effects of atropine microinjected in the left or right











Intact 20.3 ± 0.3 0.7 ± 0.3 2.3 ± 0.4
Left vehicle 32.4 ± 9.0 0.4 ± 0.05 1.6 ± 0.13
Left atropine 27.2 ± 5.5 0.2 ± 0.03 2.4 ± 0.8
Right vehicle 33.4 ± 4.9 0.5 ± 0.02 1.2 ± 0.09
Right atropine 21.6 ± 1.9 0.4 ± 0.09 1.2 ± 0.3
Proestrus 17:00 h
Intact 15.7 ± 2.9 22.8 ± 1.9 7.2 ± 0.50
Left vehicle 23.6 ± 6.0 24.9 ± 2.5 4.9 ± 2.5
Left atropine 3.9 ± 0.9abc 3.6 ± 1.5a 98.8 ± 4.4abc
Right vehicle 37.2 ± 1.3 20.7 ± 1.8 4.1 ± 0.2
Right atropine 33.2 ± 10.2 21.2 ± 2.6 8.3 ± 2.5
The mean ± SEMs for the estradiol, LH and FSH of rats subjected to microinjection
of vehicle or atropine into the left or right POA-AHA, at 13:00 h of diestrus-2 day,
and sacrificed at 11:00 or 17:00 h on the predicted proestrus day
ap < 0.01 vs. Left vehicle (ANOVA, followed Tukey test)
bp < 0.01 vs. right atropine (ANOVA, followed Tukey test)
cp < 0.01 vs. intact group (ANOVA, followed Tukey test)
Table 5 Effects of ULO performed at 13:00 h on diestrus-2 day









Intact 20.3 ± 0.3 0.7 ± 0.30 2.3 ± 0.4
Left laparotomy 14.5 ± 4.0 0.4 ± 0.06 2.0 ± 0.1
Left ULO 61.4 ± 16.1ab 1.3 ± 0.20a 42.1 ± 14.7ab
Right laparotomy 13.0 ± 4.8 0.4 ± 0.01 2.7 ± 0.6
Right ULO 12.4 ± 3.5 2.2 ± 0.40a >100a
Proestrus 17:00 h
Intact 15.7 ± 2.9 22.8 ± 1.90 7.2 ± 0.50
Left laparotomy 10.8 ± 0.5 12.5 ± 0.01 5.2 ± 0.50
Left ULO 11.5 ± 2.1 0.5 ± 0.10a <0.040ab
Right laparotomy 10.7 ± 1.3 19.4 ± 0.2 8.8 ± 0.8
Right ULO 15.9 ± 3 1.4 ± 0.10a 2.1 ± 1.04a
The mean ± SEMs for the estradiol, LH and FSH of rats subjected to left or right
laparotomy, and left or right ULO at 13:00 h of diestrus-2 day, and sacrificed at
11:00 or 17:00 h on the predicted proestrus day
ap < 0.01 vs. corresponding laparotomy (MANOVA, followed Tukey test)
bp < 0.02 vs. Right ULO (Student “t” test)
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Tanaka et al. [22] have suggested that peritoneal in-
nervation plays an essential role in the neural connec-
tion with the central nervous system. In the current
study, the effects of laparotomy on ovarian weight sup-
ports that idea because the weight of the ovaries in rats
with laparotomy on the right side was greater than in in-
tact animals, possibility meaning that a higher number
of follicles were growing. Previous studies by our group
showed the participation of the muscarinc system on es-
tradiol secretion in hemiovariectomized rats by laparot-
omy, these animals displayed an increase of LH and FSH
at 11:00 h on the predicted proestrus day suggesting that
nerve signal of the ovaries are involved in the regulation
of gonadotropin secretion on the proestrus day [23].
Also our group has shown that the removal of the right
ovary at 13:00 h on diestrus-2 day resulted in lower E2
levels than in rats with perforation in the right side of
the dorsal peritoneum, suggesting that it is neural com-
munication with the ovaries what modulates the secre-
tion of E2. Based on this previous study and the current
results, we postulate that extirpating the left ovary re-
sults in the concomitant removal of an inhibitory signal
modulating E2 secretion by the right ovary [23].
Mechanisms altered by the removal of an ovary are taken
over by the remaining ovary. All rats with the left ovary in
situ (right ULO) ovulated after injection of EB, while the EB
had no effect when the right ovary remained in situ (left
ULO). Despite the different effects on the levels of E2 in
ULO rats, the levels of FSH and LH increased in the morn-
ing of predicted proestrus day and decreased in the after-
noon, suggesting that other mechanisms led to increased
serum gonadotropin levels. One such mechanism could be
down-regulation of E2 of estrogen receptors in the hypothal-
amus and/or pituitary as previously proposed [17, 24]. Clas-
sic cholinergic synapses have rarely been observed in
GnRHergic neurons, suggesting the presence of a predomin-
antly non-synaptic path in this communication of the
cholinergic neuronal system [13]. The current results in rats
with muscarinic temporal blockade in the right POA-AHA
support previous hypothesis stating that muscarinic
neuroendocrine mechanisms regulating ovulation are
dependent on the neural information arising from the ovar-
ies and reaching the POA-AHA [12]. It is also likely that a
combination of two events is at play here: 1) the absence of
estrogen α-receptor in POA-AHA secondary to the block-
ade of muscarinic receptors as previously shown [25]; and/
or 2) a decrease in the number of high affinity sites in the
POA and adenohypophysis as suggested [26] as a conse-
quence of changes on hormonal input [23] caused by ULO.
Together, these two pieces of evidence allowed us to postu-
late that acetylcholine mediates, via muscarinic receptors,
the feedback effects of gonadal hormones on the secretion
of gonadotropins. There is evidence that the ovaries have
neural connections with several brainstem nuclei and that
representation of the left ovary in the central nervous system
is greater than that of the right ovary [27]. In intact 4-day
cyclic rats, the left ovary released more eggs than the right
[28], and the ability of each ovary to respond to the same
endocrine signals was different and variable throughout the
estrous cycle [19, 23, 29, 30]. These findings suggest that
asymmetric responses of the ovaries to neuroendocrine sig-
nals are the result of differences in the innervation received
by each ovary and intrinsic differences between them. The
current results support this idea because the number of ova
shed by the right ovary was higher than that by the left ovary
in ULO rats with mAChR blockade that were injected with
LHRH or EB.
Conclusions
Taken together, the present results confirmed that at
13:00 h of diestrus-2 day, activation of mAChRs on the left
side of the POA-AHA is required for the preovulatory
secretion of GnRH and LH necessary for ovulation.
Additionally, stimulation of these receptors is a key compo-
nent of the stimulatory feedback of estrogens. We propose
that the muscarinic system in the right POA-AHA partici-
pates in a feedback effect, by steroid hormones, on the pre-
ovulatory secretion of gonadotropins and ovulation.
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